At FirstHealth, we know that obesity is a complex, chronic medical condition—not a matter of willpower or quick fixes. That’s why our Medical Weight Management program takes a personalized, science-based approach to uncover the root causes of weight gain and build realistic, sustainable treatment plans.
The program is led by Ann Marie Richards, M.D., a board certified obesity medicine physician with a background in primary care and specialized training in plant-based nutrition. Dr. Richards brings both clinical expertise and compassion to her work, guiding patients through options that can truly change lives. With the convenience of virtual visits, patients can access care from wherever they are.
We asked Dr. Richards to weigh in on the latest headlines about new weight-loss medications and what these advances could mean for the future of treatment—especially with the promise of oral GLP-1 therapies.
The Future of Weight-Loss Medications: Why Oral GLP-1 Options Could Be a Game-Changer
There’s been a lot of buzz recently about the next generation of weight-loss medications—and for good reason. As an obesity medicine specialist, I’m encouraged by the progress we’re seeing. We now have several injectable medications that help people achieve 15 to 20% weight loss, and more options are on the way. That matters because nearly 70% of people struggle with weight management, and obesity is often linked with other metabolic health issues—even for people who don’t appear overweight.
The reality is that no single medication works for everyone. Having a larger “toolbox” gives us flexibility to tailor treatments and improve outcomes for more patients.
Why Oral GLP-1 Medications Matter
One of the most exciting developments is the arrival of oral GLP-1 medications. Up until now, these medications have almost always been injectables. Moving to a pill could make treatment:
- More convenient- no needles required
- More affordable- pills may be less expensive to manufacture, which could help reduce cost barriers
- More accessible- easier to store, distribute and prescribe
Cost is one of the biggest obstacles patients face today. Even highly effective treatments are out of reach if insurance won’t cover them or if the price remains too high. Oral options could help change that.
What Patients Should Know About Weight-Loss Medications
These new medications are promising, but they’re not a quick fix. Like blood pressure or cholesterol medicines, weight-loss medications usually require long-term use. Stopping suddenly often leads to weight regain, which can be more harmful than staying on treatment consistently.
It’s also important to remember that for individuals with a very high BMI, medications may not provide the same level of results as bariatric surgery. Surgery still outperforms medications when it comes to sustained, significant weight loss.
Beyond the Number on the Scale
Another area of innovation is in protecting muscle during weight loss. Research shows that up to 20% of weight lost on current medications can be muscle mass, not fat. That’s why providers emphasize pairing the adequate protein intake and strength training. Whether it’s working out at a gym or short body-weight workouts at home, small, sustainable steps help preserve muscle while targeting the fat that drives high blood pressure, cholesterol and other risks.
The Bottom Line
Obesity is a chronic disease—just like high blood pressure—and it requires ongoing, individualized care. The rapid advances we’re seeing, especially with oral medications, bring real hope for improving both access and outcomes.
If you’re curious if weight-loss medications are right for you, the best next step is to talk with a board-certified obesity medicine provider. These specialists can help you navigate the options, set realistic expectations and build a plan that’s safe, sustainable and personalized.
